Feature Selection and Classification for High-Dimensional Incomplete Multimodal Data [PDF]
Wanyu Deng, Dan Liu, Yingying Dong
openalex +1 more source
Few-shot Learning for Unsupervised Feature Selection [PDF]
Atsutoshi Kumagai +2 more
openalex +1 more source
Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici +8 more
wiley +1 more source
Feature Selection Criteria for Real Time EKF-SLAM Algorithm
This paper presents a seletion procedure for environmet features for the correction stage of a SLAM (Simultaneous Localization and Mapping) algorithm based on an Extended Kalman Filter (EKF).
Fernando Auat Cheein +3 more
doaj
A Survey on Evolutionary Computation Approaches to Feature Selection
Bing Xue +3 more
openalex +1 more source
Low-carbon tourism destination selection by a thermodynamic feature-based method
Cheng Zhang +3 more
openalex +2 more sources
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser +14 more
wiley +1 more source
A Feature Selection Method Base on Fisher Score for Detecting SVM-Based Network Intrusions
Mohammad Hassan Nataj Solhdar
doaj
Multi-Omic Data Integration and Feature Selection for Survival-based Patient Stratification via Supervised Concrete Autoencoders [PDF]
Pedro Avelar +4 more
openalex +1 more source
Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu +18 more
wiley +1 more source

